Denton John Russel 4

What Happened

• Denton John Russel, Senior Vice President, General Counsel, and Secretary of Caris Life Sciences (CAI), was granted 63,971 restricted stock units (RSUs) on 2026-03-06. The award shows an acquisition price of $0.00 at grant (typical for RSU grants), so the reported cash value at grant is $0.

Key Details

• Transaction date: 2026-03-06; Form 4 filed: 2026-03-10 (reports the above grant).
• Transaction type/code: A — Grant/Award (restricted stock units).
• Shares granted: 63,971 RSUs; price per share at grant: $0.00; reported cash cost: $0.
• Shares owned after the transaction: not disclosed in the filing.
• Footnote: F1 — these RSUs vest according to the terms of the applicable grant agreement (vesting schedule and conditions not detailed in the Form 4).
• No indication in the filing of a 10b5-1 plan, cashless exercise, gift, or tax-withholding sale in connection with this grant.

Context

• RSU grants are compensation awards that convert to actual shares only as they vest; they do not represent an immediate market purchase or sale. Such awards are common for executives and are not a direct buy/sell signal — they reflect compensation and retention practices rather than an immediate change in insider sentiment.